OPKO Health Inc. (OPK: Quote) said it has been awarded a contract and selected to participate in a development project directed by NASA to implement the OPKO point-of-care diagnostic platform (Claros-1) with the objective of in-orbit use on the International Space Station.
OPKO noted that it will provide a panel of assays, including Vitamin D for bone metabolism, immune health, and inflammation to be used on its Claros-1 portable analyzer.
Click here to receive FREE breaking news email alerts for OPKO Health Inc. and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org